SOUTH SAN FRANCISCO, Calif., Feb. 01, 2024 Denali Therapeutics Inc. , a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier .
/PRNewswire/ The "Intranasal Drug Delivery: Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. Global Intranasal.